Komori
Kotobukiya (7809) · FactIncrease in shares issued through exercise of share acquisition rights

Capital Enhancement Through a Public Offering and Exercise of Stock Acquisition Rights

First written in FY2018. . Latest entry: FY2025.

20entries
8years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2018 – FY20252018: 22019: 320192020: 220202021: 320212022: 420222023: 220232024: 220242025: 22025
Same theme, other companies
Multifaceted fund inflows through new share issuances, treasury share disposals, and capital contributions from non-controlling shareholdersA theme 21 companies write about · 0 as a headwind · 21 as a tailwind

2 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 21 companies compared. The sentences above are computed from all 21.
Full recordFilings, disclosures and news, newest first
  1. FY2025Increase in shares issued through exercise of share acquisition rightsAnnual report

    「1 July 2024–30 June 2025 106,200 8,550,900 10,035 469,460 10,035 431,960 (Note) 1. Increase due to the exercise of stock acquisition rights.」

    During the fiscal year, 106,200 shares were additionally issued through the exercise of stock acquisition rights, while capital and capital reserves each increased by ¥10,035 thousand.
  2. FY2025-H1Continued issuance through the exercise of share acquisition rightsAnnual report

    「1 July 2024–31 December 2024 (Note) 43,200 8,487,900 4,082 463,507 4,082 426,007 (Note) The increase resulted from the exercise of subscription rights.」

    During the six-month accounting period, 43,200 shares were additionally issued through the exercise of stock acquisition rights, while capital and capital reserves each increased by ¥4,082 thousand.
  3. FY2024Continued issuance through the exercise of share acquisition rightsAnnual report

    「1 July 2023–30 June 2024 (Note) 1　4,500　8,444,700　425　459,424　425　421,924」

    During the fiscal year, 4,500 shares were additionally issued through the exercise of stock acquisition rights, while capital and capital reserves each increased by ¥425 thousand.
  4. FY2024-Q2Additional issuance through the exercise of stock acquisition rightsAnnual report

    「1 October 2023–31 December 2023 (Note) 4,500 8,444,700 425 459,424 425 421,924 (Note) The increase resulted from the exercise of subscription rights.」

    During the second quarter accounting period, 4,500 shares were additionally issued through the exercise of stock acquisition rights, while capital and capital reserves each increased by ¥425 thousand.
  5. FY2023Continued issuance through the exercise of share acquisition rightsAnnual report

    「1 July 2022–30 June 2023　15,600　2,813,400　4,422　458,999　4,422　421,499　(Note) 1. Increase due to the exercise of stock acquisition rights.」

    During the fiscal year, 15,600 shares were additionally issued through the exercise of stock acquisition rights, while capital and capital reserves each increased by ¥4,422 thousand.
  6. FY2023-Q2Additional issuance through the exercise of stock acquisition rightsAnnual report

    「1 October 2022–31 December 2022 (Note) 4,200 2,804,400 1,190 456,447 1,190 418,947 (Note) The increase resulted from the exercise of subscription rights.」

    During the second quarter accounting period, 4,200 shares were additionally issued through the exercise of stock acquisition rights, while capital and capital reserves each increased by ¥1,190 thousand.
  7. FY2023-Q1Additional issuance through the exercise of stock acquisition rightsAnnual report

    「1 July 2022–30 September 2022 (Note)　2,400　2,800,200　680　455,257　680　417,757　(Note) Increase due to the exercise of stock acquisition rights.」

    During the first quarter, 2,400 shares were additionally issued through the exercise of stock acquisition rights, while capital and capital reserves each increased by ¥680 thousand.
  8. FY2022Continued issuance through the exercise of share acquisition rightsAnnual report

    「1 July 2021–30 June 2022　21,000　2,797,800　5,953　454,576　5,953　417,076　(Note) 3. Increase due to the exercise of stock acquisition rights.」

    During the fiscal year, 21,000 shares were additionally issued through the exercise of stock acquisition rights, while capital and capital reserves each increased by ¥5,953 thousand.
  9. FY2022-Q3Additional shares issued through the exercise of stock optionsAnnual report

    「1 January 2022–31 March 2022　11,700　2,796,300　3,316　454,151　3,316　416,651　(Note) Increase due to the exercise of stock options.」

    During the third quarter accounting period, 11,700 shares were additionally issued through the exercise of stock options, while capital and capital reserves each increased by ¥3,316 thousand.
  10. FY2022-Q2Additional shares issued through the exercise of stock optionsAnnual report

    「1 October 2021–31 December 2021 6,300 2,784,600 1,786 450,834 1,786 413,334 (Note) The increase resulted from the exercise of stock options.」

    During the second quarter accounting period, 6,300 shares were additionally issued through the exercise of stock options, while capital and capital reserves each increased by ¥1,786 thousand.
  11. FY2022-Q1Additional shares issued through the exercise of stock optionsAnnual report

    「1 July 2021–30 September 2021 (Note) 1,500 2,778,300 425 449,048 425 411,548 (Note) The increase resulted from the exercise of stock options.」

    During the first quarter, 1,500 shares were additionally issued through the exercise of stock options, while capital and capital reserves each increased by ¥425 thousand.
  12. FY2021Continued issuance through the exercise of share acquisition rightsAnnual report

    「1 July 2020–30 June 2021 20,400 2,776,800 5,783 448,623 5,783 411,123 (Note) 3. Increase due to the exercise of stock acquisition rights.」

    During the fiscal year, 20,400 shares were additionally issued through the exercise of stock acquisition rights, while capital and capital reserves each increased by ¥5,783 thousand.
  13. FY2021-Q2Additional shares issued through the exercise of stock optionsAnnual report

    「1 October 2020–31 December 2020 (Note) 6,000 2,762,400 1,701 444,540 1,701 407,040 (Note) Increase due to the exercise of stock options.」

    During the second quarter accounting period, 6,000 shares were additionally issued through the exercise of stock options, while capital and capital reserves each increased by ¥1,701 thousand.
  14. FY2020Continued issuance through the exercise of share acquisition rightsAnnual report

    「1 July 2019–30 June 2020 5,400 2,756,400 1,530 442,839 1,530 405,339 (Note) 3. Increase due to the exercise of stock acquisition rights.」

    During the fiscal year, 5,400 shares were additionally issued through the exercise of stock acquisition rights, while capital and capital reserves each increased by ¥1,530 thousand.
  15. FY2020-Q2Additional issuance through the exercise of stock acquisition rightsAnnual report

    「1 October 2019–31 December 2019 (Note)　900　2,756,400　255　442,839　255　405,339　(Note) Increase due to the exercise of stock options.」

    During the second quarter accounting period, 900 shares were additionally issued through the exercise of stock options, while capital and capital reserves each increased by ¥255 thousand.
  16. FY2020-Q1Additional shares issued through the exercise of stock optionsAnnual report

    「1 July 2019–30 September 2019 (Note) 4,500 2,755,500 1,275 442,584 1,275 405,084 (Note) Increase due to the exercise of stock options.」

    During the first quarter, 4,500 shares were additionally issued through the exercise of stock options, while capital and capital reserves each increased by ¥1,275 thousand.
  17. FY2019Continued issuance through the exercise of share acquisition rightsAnnual report

    「1 July 2018–30 June 2019 23,700 2,751,000 6,718 441,309 6,718 403,809 (Note) 3. Increase due to the exercise of stock acquisition rights.」

    During the fiscal year, 23,700 shares were additionally issued through the exercise of stock acquisition rights, while capital and capital reserves each increased by ¥6,718 thousand.
  18. FY2019-Q2Additional shares issued through the exercise of stock optionsAnnual report

    「1 October 2018–31 December 2018　3,300　2,748,000　935　440,458　935　402,958　(Note) Increase due to the exercise of stock options.」

    During the second quarter accounting period, 3,300 shares were additionally issued through the exercise of stock options, while capital and capital reserves each increased by ¥935 thousand.
  19. FY2019-Q1Additional issuance through the exercise of stock acquisition rightsAnnual report

    「(Note) The increase resulted from the exercise of stock options.」

    During the quarter, the total number of shares issued increased by 17,400 through the exercise of stock options, while capital and capital reserves each increased by ¥4,932 thousand.
  20. FY2018First statedAnnual report

    「Through a public offering with 25 September 2017 as the payment date, the company increased the total number of shares issued by 300,000 shares and increased both stated capital and capital surplus by ¥276 million.」

    The disclosure states that the number of shares issued, stated capital and capital surplus increased through the public offering and exercise of share acquisition rights.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Kotobukiya yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Capital Enhancement Through a Public Offering and Exercise of Stock Acquisition Rights | KOTOBUKIYA CO.,LTD. (7809) | Komori